Intrinsic Value of S&P & Nasdaq Contact Us

Twist Bioscience Corporation TWST NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$48.25
-16%

Stock Statistics — TWST

Twist Bioscience Corporation (TWST) has a market capitalization of $3.52B and trades at $57.41. The 52-week range is 23.3-57.88.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -44.2, Earnings Per Share (EPS) of $-1.30, annual revenue of $376.57M.

The stock has a beta of 2.29, operates in the Healthcare sector.

Trading Data
Current Price$57.41
52-Week Range23.3-57.88
Volume2.92M
Avg Volume (30D)1.26M
Market Cap$3.52B
Beta (1Y)2.29
Company
IPO Date2018-10-31
Employees923
CEOEmily Marine Leproust
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS90184D1000
CUSIP90184D100
Income (Latest Year)
Revenue$376.57M
Gross Profit$191M
EBITDA$-52.1M
Operating Income$-136.26M
Net Income$-77.67M
EPS$-1.30
EPS Diluted$-1.30
Shares Outstanding$59.81M
Balance Sheet (Latest Year)
Total Assets$641.86M
Current Assets$332.97M
Cash & ST Investments$232.43M
Total Liabilities$168.9M
Total Debt$137.32M
Net Debt$-45.73M
Total Equity$472.96M
Debt / Equity0.29
Valuation Ratios
P/E Ratio-44.2
P/S Ratio9.35
P/B Ratio7.44
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message